Apnat 60mg

Apnat 60 mg contains Apalutamide as its active ingredient. This medication is classified as an anti-cancer drug and falls under the category of androgen receptor inhibitors. It is prescribed for patients with specific types of prostate cancer that have metastasized to other areas of the body and still respond to treatments that reduce testosterone (the male reproductive hormone), or for those whose cancer has not spread and is no longer responsive to such treatments.

Apnat 60 mg functions by inhibiting the effects of androgens (male reproductive hormones), thereby preventing the growth and spread of cancer cells. It is important to notify your doctor if you experience any symptoms such as chest pain, indigestion, heart attack, difficulty walking, or numbness in the face and body. This medication is not advised for pregnant women as it may pose risks to the developing fetus. Apnat 60 mg can be taken with or without food. Additionally, this drug may lead to fertility issues in males. Therefore, men should refrain from fathering children or donating sperm during treatment and for three months following the last dose. Effective birth control methods should be employed.